Arena Pharmaceuticals to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit

Rhea-AI Summary

Arena Pharmaceuticals (Nasdaq: ARNA) announced that CEO Amit D. Munshi will present a corporate update at the Jefferies Virtual Next Generation IBD Therapeutics Summit on September 23 at 1:45 PM ET. The live audio webcast will be available on Arena's investor relations website, and a replay will be accessible for 30 days post-event. Arena Pharmaceuticals aims to deliver important medicines to patients, demonstrating a commitment to innovation and stakeholder needs in a dynamic market.

SAN DIEGO, Sept. 18, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, will present a corporate update at the Jefferies Virtual Next Generation IBD Therapeutics Summit on Wednesday, September 23, at 1:45 PM ET.                                         

A live audio webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event.

About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose – deliver our important medicines to patients.

In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get our medicines to patients, and relentlessly execute until it's done.

ARENA - Care More. Act Differently.

Forward-Looking Statements
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's participation in upcoming investor conference and Arena's purpose, work, understanding, ideas, and execution. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Corporate Contact:
Megan E. Knight
Arena Pharmaceuticals, Inc.
Director, Investor Relations 
mknight@arenapharm.com
858.210.3635

Arena Media Contact: 
IR@arenapharm.com 
858.453.7200 

View original content to download multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-jefferies-virtual-next-generation-ibd-therapeutics-summit-301133917.html

SOURCE Arena Pharmaceuticals, Inc.

FAQ

What is the date and time of Arena Pharmaceuticals' presentation at the Jefferies Summit?

Arena Pharmaceuticals will present on September 23 at 1:45 PM ET.

Where can I watch the webcast of Arena Pharmaceuticals' presentation?

The webcast will be available on Arena Pharmaceuticals' investor relations section of their website.

How long will the replay of the Arena Pharmaceuticals presentation be available?

The replay will be accessible for 30 days following the event.

Who is presenting on behalf of Arena Pharmaceuticals at the summit?

CEO Amit D. Munshi will present the corporate update.

What is the focus of the Jefferies Virtual Next Generation IBD Therapeutics Summit?

The summit focuses on advancements in IBD therapeutics, with participation from various stakeholders in the industry.